1. Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014 
Chantal Reusken, Matthias Niedrig, Suzan Pas, Pedro Anda, Sylvain Baize, Remi Charrel, Antonino Di Caro, Christian Drosten, Maria Dolores Fernandez-Garcia, Leticia Franco, Stephan Gunther, Isabelle Leparc-Goffart, Byron Martina, Delphine Pannetier, Anna Papa, Maria Paz Sanchez-Seco, Olli Vapalahti, Marion Koopmans 
Journal of Clinical Virology 
Volume 62, Pages (January 2015)
DOI: /j.jcv
Copyright © 2014 Elsevier B.V. Terms and Conditions

2. Fig. 1
Algorithm for EBOV laboratory investigation based on RT-PCR techniques. It is important to notice that diagnosing a microbe from the DD list in a suspected patient, for example, a positive Malaria outcome does not exclude EVD. Co-infections with malaria have been reported from West-Africa [17] (EMLab consortium pers. comm.).
Source: Adapted from:
Journal of Clinical Virology  , DOI: ( /j.jcv )
Copyright © 2014 Elsevier B.V. Terms and Conditions

3. Fig. 2
Map of countries and laboratories participating in the ENIVD questionnaire on EVD laboratory capacity. Biosafety level capacity is indicated by triangle (BSL2), square (BSL3) or circle (BSL4).
Journal of Clinical Virology  , DOI: ( /j.jcv )
Copyright © 2014 Elsevier B.V. Terms and Conditions

4. Fig. 3
Inventory of origins of in-house RT-PCR tests for EBOV used by laboratories within the ENIVD network. References: Gibb [35]; Sanchez [41]; Ogawa [30]; Weidmann [39]; Huang [50]; Panning [34]; Towner [36].
Journal of Clinical Virology  , DOI: ( /j.jcv )
Copyright © 2014 Elsevier B.V. Terms and Conditions